Anshika Jain
Artificial intelligence is rapidly becoming an important component of modern healthcare. Machine learning systems can assist with medical image interpretation, disease-risk prediction, clinical documentation, patient monitoring, drug development, and clinical decision support. As these technologies become more capable, however, a fundamental question becomes increasingly important: Can clinicians understand why an AI system reached a particular conclusion?
This question is especially significant in high-stakes clinical environments, where AI-supported decisions may influence diagnosis, treatment, triage, medication selection, or the allocation of medical resources. A model that produces a highly accurate prediction may still be difficult to trust or safely implement if clinicians cannot understand the evidence behind its output. This is the central challenge addressed by explainable artificial intelligence (XAI).
Explainable AI seeks to make the behavior and outputs of AI systems more understandable to human users. In healthcare, this does not simply mean revealing technical details about an algorithm. Meaningful explainability involves presenting clinically relevant information that helps physicians understand the basis, limitations, uncertainty, and appropriate interpretation of an AI-generated recommendation. The U.S. Food and Drug Administration (FDA) describes explainability as relating to how the mechanisms underlying an AI system’s operation can be represented and notes that explanations can take forms such as feature attributions, saliency maps, free-text explanations, and relevant examples.
The movement toward explainable clinical AI therefore represents a shift away from viewing AI as an autonomous prediction engine and toward viewing it as a component of a human-AI clinical team.
The Black-Box Problem in Clinical AI
Many contemporary AI systems, particularly deep neural networks, contain millions or even billions of learned parameters. These models can identify complex relationships in data that may not be easily expressed through conventional rules. While this capability can produce impressive predictive performance, it can also make the reasoning process difficult to interpret.
The problem becomes particularly important when the model’s output has consequences for a patient’s care. Consider an AI system that estimates a patient’s risk of deterioration and recommends closer monitoring. If the clinician cannot determine which clinical factors contributed to the risk estimate, it may be difficult to assess whether the recommendation is appropriate for that individual.
A black-box prediction can also make errors harder to identify. An AI system may learn associations that appear predictive in its training environment but have little clinical relevance. It may inadvertently rely on demographic characteristics, institutional practices, imaging artifacts, documentation patterns, or other variables that function as unintended proxies. Without appropriate transparency, these problems can remain hidden.
The issue is not simply whether an AI system is technically accurate. Clinical AI must operate within a complex environment in which clinicians interpret patient-specific evidence, consider competing diagnoses, account for uncertainty, and balance potential benefits and risks. Consequently, explainability must be evaluated in relation to clinical workflow rather than treated solely as a mathematical property of an algorithm.
Why Explainability Matters in High-Stakes Decisions
Clinical decisions differ in their consequences. An AI system recommending a low-risk administrative action does not necessarily require the same degree of transparency as a system supporting a diagnosis of cancer or determining whether a patient requires emergency intervention.
In high-stakes situations, clinicians need to understand not only what the AI predicts but also why the prediction was produced, what information was considered, what information may be missing, and under which circumstances the model may be unreliable. The FDA’s current transparency principles emphasize that information affecting risks and patient outcomes should be communicated appropriately to relevant users and that transparency should support safe and effective use.
Explainability can also support error detection. If an AI system identifies a suspicious lesion on an image, a visualization showing the region that influenced the prediction may allow a radiologist to assess whether the model is focusing on a clinically meaningful feature or an irrelevant artifact. Similarly, an EHR-based model could indicate which recent clinical measurements or historical factors contributed most strongly to its risk estimate.
However, an explanation should not automatically be interpreted as proof that an AI system is correct. An explanation may describe which features influenced a model without demonstrating that the model’s underlying reasoning corresponds to established medical causation. This distinction is essential in high-stakes healthcare.
What Explainable AI Means in Medicine
Explainability is a broad concept rather than a single technology. Different clinical applications require different forms of explanation. Some systems can use inherently interpretable models, in which the relationship between inputs and outputs can be directly examined. Other systems use complex models and apply post-hoc explanation techniques to approximate or visualize the factors associated with a prediction.
Feature attribution methods attempt to estimate which input variables contributed most strongly to an output. Techniques such as SHAP can assign importance values to features, helping users identify variables that influenced a prediction. In medical imaging, saliency maps and related visualization techniques can highlight areas of an image associated with a model’s prediction. Concept-based methods attempt to connect model behavior with clinically meaningful concepts rather than raw mathematical features.
Counterfactual explanations provide another approach. Instead of merely explaining why the model produced a particular output, a counterfactual explanation can explore how the prediction might change if relevant patient characteristics were different. In principle, this can help clinicians understand the boundaries of a model’s decision.
Recent research on transparency in medical AI identifies feature attribution, concept-based explanations, and counterfactual explanations among the techniques that can help clarify how medical AI systems process information and generate predictions.
Explainability in Medical Imaging
Medical imaging provides a useful example of why explainability matters. Deep learning systems can identify patterns in radiographs, CT scans, MRI studies, pathology slides, and other medical images. However, a prediction such as “high probability of malignancy” is considerably more useful when the clinician can determine which anatomical region or imaging features contributed to the result.
Visual explanations can help clinicians compare AI attention with their own interpretation. If an algorithm highlights a suspicious region that corresponds to a genuine radiological abnormality, the explanation may provide useful supporting evidence. If the system highlights an irrelevant area, the visualization may expose a potential failure mode.
Nevertheless, visual explanation methods must be interpreted carefully. A highlighted region does not necessarily demonstrate that the model has discovered the same pathological mechanism that a physician would identify. Visualization techniques can sometimes create an appearance of interpretability without fully revealing the internal computational process.
For this reason, explanation quality should be evaluated systematically. A useful explanation should be clinically relevant, sufficiently stable, and consistent with the intended use of the model. It should also help clinicians make better-informed decisions rather than merely making the AI appear more sophisticated.
Explainability in EHR-Based Clinical Prediction
Electronic health records create a different explainability challenge. Unlike an image, an EHR contains a mixture of structured measurements and unstructured information distributed across time. An AI system may analyze laboratory results, medications, diagnoses, procedures, vital signs, demographic characteristics, and clinical notes simultaneously.
A risk prediction generated from such information may therefore require a temporal explanation. Instead of simply identifying a single important variable, the system may need to indicate how changes in laboratory values, recent diagnoses, medication history, and previous events contributed to the assessment.
For example, a clinical deterioration model could identify several recent changes that collectively increased predicted risk. Presenting these factors in a clinically meaningful sequence may be more useful than presenting a numerical probability alone.
This illustrates an important principle: explainability should match the structure of the clinical problem. A static feature-importance chart may be insufficient for a decision involving years of longitudinal patient history. In such cases, explanations need to preserve temporal relationships and distinguish current findings from historical information.
Explainability and Clinical Language Models
Large language models and other clinical language technologies introduce new dimensions to explainability. These systems can summarize records, generate clinical documentation, answer questions, and produce natural-language recommendations. Their outputs can appear understandable because they are expressed in familiar language, but linguistic fluency does not necessarily indicate factual reliability or transparent reasoning.
A generated explanation may sound convincing while containing an unsupported inference. Therefore, clinical language models require mechanisms that connect their outputs to reliable evidence. For example, a system could identify the specific clinical record elements supporting a statement or distinguish documented facts from inferred information.
In high-stakes settings, evidence-linked explanations can be particularly valuable. Rather than providing an unsupported narrative, an AI system could identify the relevant laboratory trend, imaging finding, clinical observation, or guideline recommendation underlying its output. This approach makes the explanation more auditable and allows clinicians to independently evaluate the evidence.
The objective should therefore be evidence-grounded communication rather than simply generating persuasive explanations.
Explainability, Uncertainty and Model Limitations
An important limitation of many AI systems is that an explanation can clarify a prediction without communicating how uncertain that prediction is. In clinical practice, uncertainty is unavoidable. Symptoms can be ambiguous, diagnostic tests can conflict, patient information can be incomplete, and diseases can present differently across populations.
A responsible clinical AI system should therefore communicate uncertainty alongside its explanation. This may involve confidence estimates, prediction intervals, warnings about missing information, or notifications when a patient differs substantially from the population intervals, known biases, data-characterization gaps, underrepresented populations, and known failure modes as information that can be important for users of numerical confidence should not be confused with clinical certainty. A model can be represented in model development.
The FDA’s transparency principles specifically identify confidence intervals, known biases, data-characterization gaps, underrepresented populations, and known failure modes as information that can be important for users of machine-learning-enabled medical devices.
This is particularly important because numerical confidence should not be confused with clinical certainty. A model can be highly confident and still be wrong when presented with a case outside its validated setting. Explainability must therefore be accompanied by appropriate communication of limitations and scope.
From Explainable Models to Transparent Systems
A major misconception is that explainability alone can solve the transparency problem. In reality, clinical AI transparency extends across the entire lifecycle of a system. It begins with understanding the data used to train and validate the model and continues through deployment, monitoring, updating, and eventual retirement.
Recent research in Nature Reviews Bioengineering emphasizes that medical AI transparency needs to span data collection, model development, deployment, and ongoing monitoring. The review also highlights the importance of continual monitoring because model performance can change over time.
The FDA likewise emphasizes lifecycle transparency, including information about intended use, development data, clinical validation, performance, risks, limitations, updates, and ongoing performance monitoring.
This broader perspective changes the question from “Can we explain this prediction?” to “Can clinicians and other stakeholders understand how this system was developed, validated, deployed, updated, and used?”
Human-AI Collaboration in Clinical Decision-Making
The most meaningful role for explainable AI may be to strengthen collaboration between clinicians and AI rather than replace clinical judgment. A physician brings contextual knowledge, professional experience, communication skills, ethical reasoning, and an understanding of individual patient circumstances. AI can analyze large quantities of information and identify statistical patterns that may be difficult to detect manually.
An effective clinical AI system should allow these capabilities to complement one another. The AI provides evidence and analysis, while the clinician evaluates whether that evidence is relevant to the patient and integrates it into the broader clinical context.
The FDA’s transparency framework explicitly emphasizes the performance of the human-AI team and the importance of providing users with clear, essential information.
This means that explanation interfaces should be designed around clinical workflows. A physician working in an emergency setting may require concise, immediately actionable information, while a specialist reviewing a complex diagnostic case may need access to detailed supporting evidence.
Explainability should therefore be human-centered rather than technology-centered.
Regulatory and Governance Considerations
As clinical AI becomes increasingly integrated into healthcare, transparency is also becoming a regulatory and governance consideration. The FDA, Health Canada, and the UK’s Medicines and Healthcare products Regulatory Agency have developed joint guiding principles for transparency in machine-learning-enabled medical devices. These principles emphasize intended use, users, clinical context, performance, risks, model logic when available, limitations, and lifecycle monitoring.
The FDA’s January 2026 final guidance on clinical decision support software also addresses how certain clinical decision-support functions are evaluated under U.S. medical-device law. For software intended to allow healthcare professionals to independently review the basis for recommendations, FDA guidance identifies information such as intended use, required inputs, a plain-language description of algorithm development and validation, and relevant patient-specific information as important considerations.
These developments illustrate a broader movement toward treating transparency as part of responsible clinical AI development rather than as an optional feature.
Challenges and Limitations of Explainable AI
Despite its potential benefits, explainable AI has important limitations. First, there is no universal definition of a “good” explanation. An explanation that is useful to a data scientist may be meaningless to a physician, while a highly detailed technical explanation may overwhelm a clinician during a time correlations associated with a prediction without proving causation. Consequently,-sensitive decision.
Second, some explanation techniques are approximations rather than direct representations of the model’s internal reasoning. A post-hoc explanation may identify correlations associated with a prediction without proving causation. Consequently, explanations should not be interpreted as definitive accounts of why a model “reasoned” in a human sense.
Third, excessive information can be counterproductive. If a clinical interface displays dozens of model features, visualizations, probabilities, and technical metrics, clinicians may struggle to determine what actually matters. Explainability therefore involves not only providing information but selecting and presenting the right information.
Finally, explanations cannot compensate for poor model design. If a model has been trained on biased or unrepresentative data, providing an attractive explanation does not make its predictions clinically reliable. Explainability must therefore be accompanied by appropriate data governance, external validation, bias assessment, clinical evaluation, and monitoring.
The Future of Explainable Clinical AI
The future of explainable clinical AI is likely to move beyond isolated explanation techniques toward comprehensive transparency frameworks. Advanced systems may combine model-level information with patient-specific evidence, uncertainty estimates, relevant clinical guidelines, and examples from similar cases.
Multimodal AI will make this even more important. Future systems may simultaneously analyze medical images, laboratory results, EHR histories, genomic information, physiological signals, and clinical narratives. Explaining how these diverse information sources contributed to a prediction will be significantly more complex than explaining a model based on a single dataset.
Emerging clinical AI systems may therefore need layered explanations. A clinician could first receive a concise summary of the primary evidence supporting an output and then access deeper levels of information when necessary. This could include relevant imaging regions, laboratory trends, clinical-record passages, model limitations, uncertainty estimates, and validation information.
Such systems should also be continuously monitored after deployment. Changes in clinical practice, patient populations, equipment, documentation, and disease patterns can affect model performance. Transparency should therefore be maintained throughout the system’s operational lifecycle rather than limited to the point of initial approval.
Conclusion
Explainable AI is becoming increasingly important as artificial intelligence moves from experimental applications toward high-stakes clinical decision-making. In healthcare, an AI prediction cannot be evaluated solely by its numerical accuracy. Clinicians need to understand the evidence supporting the prediction, the limitations of the model, the uncertainty surrounding the output, and the circumstances in which the system should or should not be relied upon.
Moving beyond black-box predictions does not necessarily require abandoning sophisticated deep-learning systems. Instead, it requires developing clinical AI within a broader framework of explainability, transparency, human-centered design, evidence validation, uncertainty communication, and continuous monitoring. Explainability techniques such as feature attribution, saliency visualization, concept-based reasoning, counterfactual analysis, and evidence-linked language generation can contribute to this objective, but none should be treated as a complete solution on its own.
The future of clinical AI will ultimately depend on the quality of the relationship between humans and intelligent systems. AI should help clinicians organize complex evidence, recognize important patterns, identify uncertainty, and investigate potential diagnoses or treatment options. Clinicians, in turn, must remain able to critically evaluate AI outputs within the context of individual patients. As regulatory and scientific frameworks increasingly emphasize transparency and human-centered design, explainable AI can become an important foundation for developing clinical technologies that are not only powerful, but also understandable, accountable, and appropriately integrated into patient care.